Inventor · disambiguated record
Catherine Uyttenhove
Also filed as: UYTTENHOVE CATHERINE
18 granted patents·2 pending applications·274 citations·filing 1988–2022
94Inventor score
Files withLUDWIG INST CANCER RES9LUDWIG INST FOR CANCER RES LTD6MEDIMMUNE INC2GLAXOSMITHKLINE BIOLOG SA1SMITHKLINE BEECHAM BIOLOG1
Top patents by PatentIndex Score
20 records- 0196US9518112B2TGF-β1 specific antibodies and methods and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2013·Granted Dec 13, 2016·24 cites·20 claims
- 0293US11957751B2TGF-β1 specific antibodies and methods and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2021·Granted Apr 16, 2024·2 cites·29 claims
- 0392US10947303B2TGF-ß1 specific antibodies and methods and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2018·Granted Mar 16, 2021·4 cites·14 claims
- 0487US10035851B2TGF-β1 specific antibodies and methods and uses thereofVAN SNICK JACQUES·Filed 2016·Granted Jul 31, 2018·4 cites·12 claims
- 0584US7371383B2Recombinant anti-interleukin-9 antibodiesMEDIMMUNE INC·Filed 2003·Granted May 13, 2008·21 cites·44 claims
- 0681US12221477B2TGF-β3 specific antibodies and methods and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2022·Granted Feb 11, 2025·0 cites·36 claims
- 0777US10723793B2TGF-β3 specific antibodies and methods and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2016·Granted Jul 28, 2020·1 cites·18 claims
- 0874US5246701AMethod for inhibiting production of IgE by using IL-9 inhibitorsLUDWIG INST CANCER RES·Filed 1991·Granted Sep 21, 1993·38 cites·8 claims
- 0974US5157112AAntibodies immunoreactive with the T-cell growth factor, P40LUDWIG INST CANCER RES·Filed 1989·Granted Oct 20, 1992·27 cites·6 claims
- 1073US5208218AT cell growth factor glycoproteinsLUDWIG INST CANCER RES·Filed 1988·Granted May 4, 1993·27 cites·6 claims
- 1172US11485780B2TGF-β3 specific antibodies and methods and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2020·Granted Nov 1, 2022·0 cites·16 claims
- 1272US5116951ASubstantially pure interleukin-9 receptor and uses thereofLUDWIG INST CANCER RES·Filed 1990·Granted May 26, 1992·34 cites·4 claims
- 1365US5132109AMethod for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereofLUDWIG INST CANCER RES·Filed 1990·Granted Jul 21, 1992·23 cites·2 claims
- 1462US6375945B1Adjuvant compositions for vaccinesSMITHKLINE BEECHAM BIOLOG·Filed 1998·Granted Apr 23, 2002·27 cites·3 claims
- 1562US5180678AUses of substantially pure interleukin-9 receptorLUDWIG INST CANCER RES·Filed 1992·Granted Jan 19, 1993·22 cites·6 claims
- 1655US5164317AMethod for enhanced growth and proliferation of mast cellsLUDWIG INST CANCER RES·Filed 1991·Granted Nov 17, 1992·20 cites·8 claims
- 1755US2008299134A1Recombinant Anti-Interleukin-9 AntibodiesMEDIMMUNE INC·Filed 2008·Application pending·0 cites
- 1847US2007048261A1Vaccine comprising il-12 or il-23 for treatment of autoimmune diseasesGLAXOSMITHKLINE BIOLOG SA·Filed 2004·Application pending·0 cites
- 1931US5750377AProcess for preparing mammalian T cell growth factor P40LUDWIG INST CANCER RES·Filed 1995·Granted May 12, 1998·0 cites·8 claims
- 2031US5587302AT cell growth factorLUDWIG INST CANCER RES·Filed 1990·Granted Dec 24, 1996·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Catherine Uyttenhove files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →